admin

With a bipartisan infrastructure bill and a $3.5 trillion budget resolution making their way through Congress and looking poised to pass, I believe investors are greatly underestimating the extent to which these pieces of legislation will help General Electric (NYSE:GE) and GE stock. Source: Sundry Photography / Shutterstock.com GE operates through four industrial segments — Power,
0 Comments
Dividend growth ETFs hold companies with solid balance sheets and rising earnings. Vanguard Dividend Appreciation ETF: https://www.zacks.com/funds/etf/VIG/profile?cid=CS-YOUTUBE-FT-VID SPDR S&P Dividend ETF: https://www.zacks.com/funds/etf/SDY/profile?cid=CS-YOUTUBE-FT-VID IShares Core Dividend Growth ETF: https://www.zacks.com/funds/etf/DGRO/profile?cid=CS-YOUTUBE-FT-VID Apple: https://www.zacks.com/stock/quote/AAPL?cid=CS-YOUTUBE-FT-VID Microsoft: https://www.zacks.com/stock/quote/MSFT?cid=CS-YOUTUBE-FT-VID Visa: https://www.zacks.com/stock/quote/V?cid=CS-YOUTUBE-FT-VID Walmart: https://www.zacks.com/stock/quote/WMT?cid=CS-YOUTUBE-FT-VID Johnson and Johnson: https://www.zacks.com/stock/quote/JNJ?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: http://stocktwits.com/ZacksResearch Follow us on Twitter: https://twitter.com/ZacksResearch Like us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
0 Comments
Stock trading draws Type A personalities who are driven to win at all costs. Succeeding means logging long hours in front of a computer screen, researching, and trading stocks. But in stock trading, there’s a fine line between working hard and feeding an addiction. That line can mean the difference between making sound investment decisions
0 Comments
Cassava Sciences (NASDAQ:SAVA) stock is in a tailspin after a lab denied it had prepared recent results for the biotech’s experimental Alzheimer’s disease treatment. Source: pathdoc / Shutterstock.com Following the news, Cassava shares fell approximately 50%, eliminating roughly $2.4 billion of value over three trading days. The rejection contradicts a statement from Cassava that Quanterix
0 Comments
Although special purpose acquisition companies, or SPACs, gained notoriety over the trailing year-and-a-half period, they do offer a clear advantage to retail investors. Without these blank-check firms, regular folks may not have a chance to buy names like Skillz (NYSE:SKLZ) stock. Source: NYCStock / Shutterstock.com That’s because traditional market debuts are comparatively onerous, perhaps enough
0 Comments
Novavax (NASDAQ:NVAX) stock could trade in the $100 billion market capitalization range like BioNTech (NASDAQ:BNTX) or Moderna (NASDAQ:MRNA). Except, unlike those companies, Novavax has not yet delivered. Source: Ascannio/Shutterstock.com It might be among the most-watched firms that did not yet bring a Covid-19 vaccine to market. Chances are low that it will slump like Altimmune
0 Comments
Jumia Technologies AG (NYSE:JMIA) stock’s movement earlier in 2021 can be described in just three words. Pump and dump. Source: Christopher Penler / Shutterstock.com Sounds familiar? It should. If not, here’s a quick reminder. Wikipedia mentions that it “involves artificially inflating the price of an owned stock through false and misleading positive statements, to sell
0 Comments
Support.com (NASDAQ:SPRT) holds its special meeting on Sept. 10 to vote on its merger with Greenridge Generation Holdings. The merger’s acceptance requires that more than 50% of owners of SPRT stock vote to approve the deal. Source: Shutterstock.com The two parties announced their merger on March 22. The day before the merger announcement, SPRT closed
0 Comments